loading page

Intrapelvic Tumor Height (ITH) as a Promising Novel Prognostic Indicator for long-term functional outcomes in Sacrococcygeal Teratomas
  • +4
  • Sébastien Faraj,
  • Yousuf Al-shaqsi,
  • Pauline Lallemant-Dudek,
  • Eleonore Blondiaux,
  • Aurore COULOMB L'HERMINE,
  • Sabine Irtan,
  • Georges Audry
Sébastien Faraj
Sorbonne Universite

Corresponding Author:sebastien.fara@aphp.fr

Author Profile
Yousuf Al-shaqsi
Sorbonne Universite
Author Profile
Pauline Lallemant-Dudek
Sorbonne Universite
Author Profile
Eleonore Blondiaux
Sorbonne Universite
Author Profile
Aurore COULOMB L'HERMINE
Sorbonne Universite
Author Profile
Sabine Irtan
Sorbonne Universite
Author Profile
Georges Audry
Sorbonne Universite
Author Profile

Abstract

Background: Sacrococcygeal teratoma (SCT) is considered the most common congenital neoplasm in neonates. This study aimed to assess long-term impacts on urinary and anorectal functions and quality of life (QoL) in patients who underwent surgery for SCT and to identify predictive factors for these outcomes, with a focus on the Intrapelvic Tumor Height (ITH). Methods: This retrospective study included patients treated surgically for SCT, between 1984 and 2017 at the Armand Trousseau Hospital. Urologic and anorectal functions were evaluated through clinical assessments and patient-reported outcomes through questionnaires. Statistical analysis was performed to explore correlations between these factors and long-term functional outcomes. Results: Twenty-six patients (median age=17 years) were identified. With a median follow-up of 180 months [96-444 months], 12 patients (46%) presented functional impairments: seven had isolated anorectal dysfunction and five had both urinary and anorectal dysfunctions, including neurogenic bladder (n=2) and/or detrusor-sphincter dyssynergia (n=3). A significant correlation was observed between adverse outcomes and intrapelvic tumor height (ITH) (median ITH was 27 mm in patients with impairments versus 15 mm in those without, p<0.05). Of the 12 questionnaire respondents, two patients experienced urinary and anorectal dysfunctions and five experienced isolated anorectal dysfunction. Most patients reported a good QoL, only one patient reporting a severe impact on daily life. Conclusions: This study highlights that long-term urologic and anorectal dysfunctions are prevalent in patients treated for SCT, although the overall impact on quality of life remains moderate. Importantly, ITH emerged as a more objective and accurate predictor of functional outcomes than tumor size or Altman classification.